Literature DB >> 2759489

Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis.

P Sipponen1, K Seppälä, M Aärynen, T Helske, P Kettunen.   

Abstract

Chronic (atrophic) gastritis (AG) is common in active duodenal (DU) and gastric ulcer (GU) disease. In this case control study in consecutive prospective outpatients (571 cases and 1074 controls) who had undergone diagnostic upper gastrointestinal endoscopy and routine biopsies from both antral and body mucosa, we calculated the risk of coexisting active DU and/or GU in different gastritis of the antrum or body and according to grade (superficial gastritis, mild, moderate or severe atrophic gastritis). The risk of coexisting active gastroduodenal ulcer (ulcer in duodenum and/or stomach), as well as the risk of DU or GU, was dependent upon the presence and grade of gastritis in antrum and body mucosa. The risk of coexisting ulcer, as expressed as an age adjusted relative risk (RR) and calculated as odds ratio of gastritis in cases and controls, was significantly increased in the presence of superficial antral and body gastritis (RR = 8.5 (7.0-20.0) in men; RR = 5.8 (3.3-10.2) in women), as compared with the risk of ulcer in subjects with histologically normal mucosa (RR = 1). The risk of ulcer, and the risk of GU in particular, increased further with increasing severity of antral gastritis. In such patients with moderate or severe atrophic antral gastritis the RR of coexisting ulcer even exceeded 20 in men and 10 in women (RR = 25.6 (9.0-72.7) in men; RR = 11.7 (5.9-23.0) in women). On the other hand, the RR of ulcer, and the RR of DU in particular, was below 1 in the presence of atrophic gastritis in the gastric body, irrespective of the grade of gastritis in the antrum. We conclude that the type and grade of gastritis strongly predicts the risk of coexisting peptic ulcer, and that the risk of coexisting DU or GU increases with an increase in grade of AG of the antrum but decreases with an increase in grade of AG of the gastric body.

Entities:  

Mesh:

Year:  1989        PMID: 2759489      PMCID: PMC1434292          DOI: 10.1136/gut.30.7.922

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  The relationship between the acid output of the stomach following "maximal" histamine stimulation and the parietal cell mass.

Authors:  W I CARD; I N MARKS
Journal:  Clin Sci       Date:  1960-02       Impact factor: 6.124

2.  A theory to the stochastic dynamic model building for chronic progressive disease processes with an application to chronic gastritis.

Authors:  E Hovinen; M Kekki; S Kuikka
Journal:  J Theor Biol       Date:  1976-03       Impact factor: 2.691

3.  Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random.

Authors:  M Siurala; M Isokoski; K Varis; M Kekki
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

Review 4.  Newer concepts in the pathogenesis of peptic ulcer disease.

Authors:  A Ippoliti; J Walsh
Journal:  Surg Clin North Am       Date:  1976-12       Impact factor: 2.741

5.  The antrum in duodenal ulcer patients. Relationship between antrum size, nerve of Latarjet, gastrin cell quantity, and gastric acid secretion.

Authors:  H O Nielsen; J D Muñoz; O Kronborg; D Andersen
Journal:  Scand J Gastroenterol       Date:  1981       Impact factor: 2.423

6.  Gastric ulcer and gastritis.

Authors:  M W Gear; S C Truelove; R Whitehead
Journal:  Gut       Date:  1971-08       Impact factor: 23.059

7.  Epidemiologic pathology of gastric ulcer and gastric carcinoma among Japanese in Hawaii.

Authors:  G Stemmermann; W Haenszel; F Locke
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

8.  Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.

Authors:  I M Samloff; G N Stemmermann; L K Heilbrun; A Nomura
Journal:  Gastroenterology       Date:  1986-03       Impact factor: 22.682

9.  Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis.

Authors:  M Kekki; P Sipponen; M Siurala
Journal:  Scand J Gastroenterol       Date:  1984-05       Impact factor: 2.423

10.  Histological appearances of oesophagus, antrum and duodenum and their correlation with symptoms in patients with a duodenal ulcer.

Authors:  R J Earlam; J Amerigo; T Kakavoulis; D J Pollock
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

View more
  20 in total

Review 1.  Presentation and management of Helicobacter pylori infection in childhood.

Authors:  U Blecker; N K Mittal; D I Mehta
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

Review 2.  Role of Helicobacter pylori in duodenal ulcer.

Authors:  E A Rauws
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

3.  Duodenal ulcer: the villain unmasked?

Authors:  A R Axon
Journal:  BMJ       Date:  1991-04-20

4.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

5.  Gastritis staging in clinical practice: the OLGA staging system.

Authors:  Massimo Rugge; Alberto Meggio; Gianmaria Pennelli; Francesco Piscioli; Luciano Giacomelli; Giovanni De Pretis; David Y Graham
Journal:  Gut       Date:  2006-12-01       Impact factor: 23.059

6.  Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.

Authors:  Katsunori Iijima; Yasuhiko Abe; Ryosuke Kikuchi; Tomoyuki Koike; Shuichi Ohara; Pentti Sipponen; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

7.  Histological study of chronic gastritis from the United Arab Emirates using the Sydney system of classification.

Authors:  A M Zaitoun
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

8.  Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently.

Authors:  A Hackelsberger; U Platzer; M Nilius; V Schultze; T Günther; J E Dominguez-Muñoz; P Malfertheiner
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

9.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

Authors:  A S Taha; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

10.  Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects.

Authors:  Hirotsugu Watabe; Toru Mitsushima; Mohammad H Derakhshan; Yutaka Yamaji; Makoto Okamoto; Takao Kawabe; Masao Omata; Kenneth E L McColl
Journal:  Dig Dis Sci       Date:  2008-09-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.